Human BAFF-R(CD268) Recombinant

Catalog #
90103-A
$130 *
Size: 10 µg
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Recombinant human BAFF-R (B cell-activating factor from the TNF family), also known as CD268, is a disulfide-linked monomeric protein consisting of 76 a.a. and migrates as an approximately 9 kDa protein under reducing and non-reducing conditions. Optimized DNA sequence encoding human BAFF-R extracellular domain was expressed in E. coli.

Synonyms
BAFF-R, B cell-activating factor from the TNF family, CD268
Product Info
Storage and Usage
Citations
Species
Human
Host Species/Expression System
E. coli
Purity
≥95% by SDS-PAGE and HPLC
Format
lyophilized protein
Formulation
Lyophilized from a 0.2 µm filtered solution containing 2.5% glycine, 0.5% sucrose, 0.01% Tween-80, 5 mM glutamic acid, pH 4.5.
MW
9 kDa
Endotoxin Level
<0.1 ng/µg (1 EU/µg), using the LAL gel clot method.
Amino Acids
1–78
Biological Activity
The ED50 , determined by the ability to block BAFF induced survival of splenocyte cells, was found to be in the range of 1.0-5.0 µg/ml.
Genbank #
Q96RJ3
UniProt #
Q96RJ3
Background
The B cell-activating factor from the TNF family (BAFF), is emerging as an important regulator of B cell and T cell responses. BAFF was originally identified as a factor responsible for B cell survival and maturation .BAFF binds to several receptors. These include transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI), BAFF-R (BR3), and B cell maturation Ag (BCMA). BAFF-R appears to be particularly important for the regulation of B cell survival and maturation in the spleen, because A/WySnJ mice expressing a defective BAFF-R have disrupted B cell maturation, similar to that seen in BAFF-deficient mice.
References
1. The effects of BAFF and BAFF-R-fc fusion protein in immune thrombocytopenia. Blood, Dec 2009, 114: 5362 - 5367.
2. c-rel in the regulation of BAFF-R expression in malignant human B cells. Blood (ASH Annual Meeting Abstracts), Nov 2009, 114: 2400.